News
Depression & Stress Could Dampen Efficacy of COVID-19 Vaccines
Decades of research show that depression, stress, loneliness, and poor health behaviors can weaken the body's immune system and lower the effectiveness of certain vaccines.
New Promising Antibodies against SARS-CoV-2
An international research team led by the University of Bonn has identified and further developed novel antibody fragments against SARS-CoV-2, the virus that causes COVID-19.
Experimental coronavirus vaccine highly effective
Researchers have been working to develop a safe and effective vaccine against SARS-CoV-2, the coronavirus that causes COVID-19. One vaccine candidate, called mRNA-1273, is being developed by researchers at NIH’s National Institute of Allergy and Infectious Diseases (NIAID) and the biotech company Moderna, Inc. Early results showed it can trigger an immune response against the virus without serious side effects.
University of Vermont Microbiology Laboratory Identifies Inefficiencies When Performing Pooled Testing for COVID-19
Experts believe pooled testing for COVID-19 could reduce the number of standard tests for SARS-CoV-2 by conserving testing resources and cutting lab spending on tests and testing supplies.
Exposure to Common Foodborne Pathogen Linked to Rare Brain Cancer
A new study suggests a link between toxoplasma gondii (T. gondii) infection and the risk of glioma, a type of brain cancer, in adults.
Virtual Realities, Real Discoveries
As the newest frontier in entertainment, virtual reality (VR) conjures fictional worlds where soaring over skyscrapers or battling supernatural enemies are as easy as a flick of the wrist. But in her lab, Susan Persky, Ph.D., uses VR in a more practical context.
Landmark Clinical Trial Reveals Link between Gut Microbes, Diet, and Illness
Diets rich in healthy and plant-based foods encourage the presence of gut microbes that are linked to a lower risk of common illnesses including heart disease, a recent clinical trial has found.
C₂N Diagnostics Releases PrecivityAD, the First Clinical Laboratory Blood Test for Alzheimer’s Disease
Clinical laboratories have long awaited a test for Alzheimer’s disease and the wait may soon be over. The first blood test to aid physicians and clinical laboratories in the diagnosis of patients with memory and cognitive issues has been released by C₂N Diagnostics of St. Louis.
We need your help to grow this newsletter! Please pass along the subscription link to any colleague you think would benefit from hearing about med lab news.